A Standard Controlled Clinical Evaluation of Swedana and Agnikarma in Cervical Spondylosis (Manyastambha)

  • Harpreet Singh Post Graduate Scholar, Department of Panchakarma, Uttarakhand Ayurved University, Rishikul Campus, Haridwar, Uttarakhand, India.
  • K. K. Sharma Professor and HOD, Department of Panchakarma, Uttarakhand Ayurved University, Rishikul Campus Haridwar, Uttarakhand, India
  • Gyanendra Datta Shukla Associate Professor, Department of Panchakarma, Uttarakhand Ayurved University, Gurukul Campus, Haridwar, Uttarakhand, India
  • Deepak Kumar MBBS, MS, FNB Orthopedic Spinal Surgeon, RKMS Hospital, Haridwar, Uttarakhand, India
Keywords: Cervical spondylosis, Manyasthamba, Swedana, Agnikarma, Ruksha Baluka Swedana, Punnagadi Patra Potali Swedana

Abstract

As exertion and stress is increasing day-by-day, diseases also increased in our daily routine. Prolonged sitting work, desktop work and continuous household work led to it. Degeneration of cervical spine components, such as facet joints and intervertebral discs, is known as cervical spondylosis. This degenerative process frequently causes stiffness, pain, and possible nerve compression in the neck, which can result in radicular symptoms such as upper extremity pain, numbness, or weakness. In Manyasthamba there is Vata Avarana by Kapha which later turns out to Kevala Vata Vyadhi. So, the present study aims at integrating Ayurvedic treatments with conventional approaches for cervical spondylosis addresses the condition holistically and treating not just the symptoms but also the root causes. The study entitled “A standard controlled clinical evaluation of Swedana and Agnikarma in cervical spondylosis (Manyastambha)” was conducted in 60 patients. They were selected on the basis of standard inclusion and exclusion criteria and randomly allocated to two different groups; Group - A (Ruksha Baluka Swedana, Punnagadi Patra Potali Swedana, Agnikarma) and Group - B (Controlled drug i.e., Pregabalin, Methyl cobalamin, Etoricoxib, Thiocolchicoside). Total duration of the treatment was of 16 days along with a follow-up period of 30 days. Both the intervention was effective, but in overall improvement of the patients “Group A” had shown better result along with long lasting effect in comparison with “Group B”.

Downloads

Download data is not yet available.

References

Allagappan R. Manual of Practical Medicine. 6th ed. Jaypee Brothers Medical (P) Ltd.; 2018. p. 720.

Agnivesha. Charaka Samhita. In: Sastri K, Chaturvedi G, editors. Vidyotini Hindi commentary. Reprint ed. Delhi: Chaukhambha Sanskrit Pratishthan; 2015. Sutra Sthana, 20/11. p. 399.

Shastri AD. Sushrut Samhita. Purvardh Nidan Sthan 1/67. In: Shastri AD, editor. Ayurved Tattav Sandipika Hindi commentary. Varanasi: Chaukhambha Orientalia; Part 1. p. 303.

Agnivesha. Charaka Samhita. In: Sastri K, Chaturvedi G, editors. Vidyotini Hindi commentary. Reprint ed. Delhi: Chaukhambha Sanskrit Pratishthan; 2015. Sutra Sthana, 14/25-26. p. 286.

Overview. Available from: https://emedicine.medscape.com/article/306036-overview#a6. Accessed 2019 Apr 25.

Scientific reports. Available from: https://www.omicsonline.org/scientific-reports/srep193.php.Accessed 2019 Apr 25.

Scientific reports. Available from: https://www.omicsonline.org/scientific-reports/srep193.php.Accessed 2019 Apr 25.

CITATION
DOI: 10.21760/jaims.10.1.5
Published: 2025-03-06
How to Cite
Singh, H., K. K. Sharma, Shukla, G. D., & Kumar, D. (2025). A Standard Controlled Clinical Evaluation of Swedana and Agnikarma in Cervical Spondylosis (Manyastambha). Journal of Ayurveda and Integrated Medical Sciences, 10(1), 28 - 39. https://doi.org/10.21760/jaims.10.1.5
Section
Original Article